Emily Rapasadi
Medical · Glens Falls, NYNPI 1346655354
Payments from drug & device makers
Across 152 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$682
- AbbVie$513
- Lilly USA, LLC$446
- GSK$256
- Amgen$200
- Pfizer$106
- plus $798 from 19 others
What the payments were for
- Food & beverage$3,001100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $682 |
| AbbVie | 23 | $513 |
| Lilly USA, LLC | 23 | $446 |
| GSK | 14 | $256 |
| Amgen | 10 | $200 |
| Pfizer | 5 | $106 |
| AstraZeneca | 5 | $103 |
| Johnson & Johnson | 5 | $82 |
| Boehringer Ingelheim | 3 | $73 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Indivior Inc. | 3 | $63 |
| Idorsia Pharmaceuticals US Inc | 3 | $58 |
| Dexcom, Inc. | 2 | $55 |
| Astellas Pharma US Inc | 2 | $48 |
| Merck | 2 | $42 |
| Exact Sciences | 1 | $33 |
| Boston Scientific | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Abbott | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
How this compares
$3,001 in reported general payments places this provider in the 80th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $72,491 |
| JardianceEmpagliflozin | 41 | $65,188 |
| OzempicSemaglutide | 50 | $53,634 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $27,583 |
| MyrbetriqMirabegron | 33 | $21,207 |
| MounjaroTirzepatide | 19 | $18,834 |
| TrulicityDulaglutide | 17 | $17,990 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $11,022 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $7,322 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $7,227 |
| Atorvastatin Calcium | 523 | $6,198 |
| Repatha SyringeEvolocumab | 12 | $6,014 |
| Rosuvastatin Calcium | 315 | $5,616 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $5,192 |
| Potassium Chloride | 111 | $4,279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $73 | $72,51054 claims |
| PfizerEliquis | $106 | $72,49181 claims |
| Novo NordiskOzempic | $682 | $53,63450 claims |
| Lilly USA, LLCMounjaro, Trulicity | $446 | $36,82436 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $256 | $32,77542 claims |
| Astellas Pharma US IncMyrbetriq | $48 | $21,20733 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $3,160213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,395 medical providers in New York.
Other medical in Glens Falls
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.